In our differential gene expression analysis and GSEA, most enriched genes are involved in tumor aggressiveness and drug resistance including ABHD2, ABCC4, CLN5 intracellular trafficking protein, and insulin like growth factor 2 receptor. This evidence concerns the gene CLN5 and neoplasm.